Skip to Content search facebook instagram pinterest twitter youtube

Publications

TTANGO and TTANGO2 Publications

 

 

 

 

An innovative connectivity solution for national decentralised infectious diseases testing programs in regional and remote primary health services in Australia (oral abstract)

Saha et al. 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023), Sydney (March 2023)  https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/f0ada0a8fe9a467690623e9ffe9a0bca

 

Acceptability among healthcare workers and clinic managers on the uptake of molecular point-of-care testing for Trichomonas vaginalis

Tangey et al. (poster abstract) 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023), Sydney (March 2023) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/5f7274a1289444a4ad6167ea2cc170d5

 

Assessment of the training and quality systems for the TTANGO3 (Test, Treat And GO) sexually transmitted infection (STI) point-of-care testing network

Shephard et al. (oral abstract) 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023), Sydney (March 2023) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/4f4f5e4d372c46c79a6a52c5649f8413

 

A flexible and innovative connectivity solution to support national decentralised infectious diseases point-of-care testing programs in primary health services in Australia

Saha, A., Andrewartha, K., Badman, S., Tangey, A., Smith, K., Sandler, S., Ramsay, S., Braund, W., Margison, S. M., Matthews, S., Shephard, M., Guy, R., Causer., L. A flexible and innovative connectivity solution to support national decentralised infectious diseases point-of-care testing programs in primary health services in Australia. JMIR Preprints (2023). http://doi.org/10.2196/preprints.46701

 

Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators.

Lafferty, L., Smith, K., Causer, L., Andrewartha, K., Whiley, D., Badman, S. G., Donovan, B., Anderson, L., Tangey, A., Mak, D., Maher, L., Shephard, M., Guy, R. Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators. Implement Sci Commun 2, 127 (2021). https://doi.org/10.1186/s43058-021-00232-8

 

From trial to program: TTANGO2 scale-up and implementation sustains STI point-of-care testing in regional and remote Australian Aboriginal health services (poster abstract).

L. Causer et al. STI and HIV World Congress (virtual conference), (July 2021) http://dx.doi.org/10.1136/sextrans-2021-sti.269

 

The Cost-Effectiveness and Impact of Molecular Point of Care Testing for Chlamydia and Gonorrhea on the Reproductive Health of Indigenous Women in Remote Australian Communities (oral abstract).

C.Watts et al. International Health Economics Association Congress (virtual conference), (July 2021) https://healtheconomics.confex.com/healtheconomics/2021/meetingapp.cgi/Paper/5892

 

The cost-effectiveness of molecular point of care testing for chlamydia and gonorrhoea in remote communities (oral abstract).

C. Watts et al. Health Services Research Association of Australia and New Zealand (HSRAANZ) conference, Auckland NZ (December 2019) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/97ab2b27023840709bfc28b4cecf95b4

 

Presumptive treatment for chlamydia and gonorrhoea in remote Aboriginal health services (oral presentation).

K. Smith et al. ASHM conference, Perth (September 2019). https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/bc01c05cea164ba2a3146f4c85289b8a

 

Sustainability of point-of-care testing for sexually transmissible infections in remote communities in Australia – transition from trial to program (oral abstract).

R. Guy et al. IUSTI conference, New Zealand (November 2018). https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/451e41a668454a07885fb681b1f97529

 

Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.

R. Guy et al. The Lancet Infectious Diseases (October 2018). https://pubmed.ncbi.nlm.nih.gov/30303108/

 

The TTANGO Trial Final Report To Health Services May 2018

Read the final report

 

Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation.

Causer LM, Guy RJ, Tabrizi SN, Whiley D, Speers D, Ward J, Tangey A, Badman SG, Hengel B, Natoli L, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM. Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation. Sexually Transmitted Infections (accepted 2018). https://doi.org/10.1136/sextrans-2017-053443

 

A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing.

Badman SG, Causer LM, Guy R, Wand H, Donovan B, Tabrizi S, Speers D, Shephard MD, Vallely A, Whiley D on behalf of the TTANGO investigators. A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing. Pathology 2018;50: 317-321. https://doi.org/10.1016/j.pathol.2017.09.012

 

Translating the TTANGO Trial into Routine Practice - Poster Presented at National Rural Health Conference April 2017

View Poster

 

A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis.

Badman SG, Causer LM, Guy R, Tabrizi S, Francis F, Donovan B, Whiley D on behalf of the TTANGO Investigators (including Shephard M). A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis. Sexually Transmitted Infections 2016; 92: 350-352. http://dx.doi.org/10.1136/sextrans-2015-052384

 

A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.

Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, et al. “I Do Feel Like a Scientist at Times”: A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting. PLoS ONE 2015; 10(12): e0145993. http://dx.doi.org/10.1371/journal.pone.0145993

 

Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.

Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L on behalf of the TTANGO investigator group. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJOpen 2015; 5:e006922. http://doi:10.1136/bmjopen-2014-006922

 

Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used?

Natoli L, Guy RJ, Shephard M, Donovan B, Fairley C, Ward J, Regan D, Hengel B, Maher L on behalf of the TTANGO Investigators. Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used? Sexual Health 2015; 12: 51-58. http://dx.doi.org/10.1071/SH14213

 

Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

Natoli L, Maher L, Shephard M, Hengel B, Tangey A, Badman S, Ward J, Guy R on behalf of the TTANGO investigators. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice. PLoS ONE 2014; 9(6): e100518. http://dx.doi.org/10.1371/journal.pone.0100518

 

A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol.

Guy R, Natoli l, Ward J, Causer L, Hengel B, Whiley D, Tabrizi S, Donovan B, Fairley C, Badman S, Tangey A, Wand H, Shephard M, Regan D, Wilson D, Anderson D, Kaldor J. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol. BMC Infectious Diseases 2013; 13: 485. http://doi:10.1186/1471-2334-13-485

 

Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.

Tabrizi S, Unemo M, Golparian D, Twin J, Limnios A, Lahra M, Guy R, Ward J, Kaldor J, Donovan B, Wilson D, Wand H, Regan, D, Causer L, Hengel B, Natoli L, Anderson D, Whiley D, Shephard M, Fairley, C. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Clinical Microbiology 2013; 51: 1945-1947. https://doi.org/10.1128/jcm.00806-13